Suchergebnisse - "Rudenko, Larisa"

PubPharm (188)

101

Cold-adapted influenza viruses as a promising platform for viral-vector vaccines

enthalten in: Expert review of vaccines | 2016

von Isakova-Sivak, I. | Tretiak, T. | Rudenko, L.

102

Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories

enthalten in: Vaccine | 2016

von Rudenko, L. | Yeolekar, L. | Kiseleva, I. | +1

103

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu

enthalten in: BMC Proceedings | 2015

von Nechaeva, E. | Bogryantseva, M. | Ryzhikov, A. | +9

104

Phase I clinical trials of safety and immunogenicity of live cultural influenza vaccine vector-flu

enthalten in: BMC proceedings | 2015

von Nechaeva, E. | Bogryantseva, M. | Ryzhikov, A. | +9

105

Will there ever be a new influenza pandemic and are we prepared?

enthalten in: Vaccine | 2015

von Rudenko, L. | Sellwood, C. | Russell, C. | +3

106

Genetic stability of live attenuated vaccines against potentially pandemic influenza viruses

enthalten in: Vaccine | 2015

von Kiseleva, I. | Dubrovina, I. | Fedorova, E. | +7

107

Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses : Geneva, Switzerland, 5-7 May 2014

enthalten in: Vaccine | 2015

von Cox, N. | Hickling, J. | Jones, R. | +8

108

Clinical testing of pre-pandemic live attenuated A/H5N2 influenza candidate vaccine in adult volunteers : results from a placebo-controlled, randomized double-blind phase I study

enthalten in: Vaccine | 2015

von Rudenko, L. | Kiseleva, I. | Stukova, M. | +20

109

STRAIN A/17/Texas/2012/30 (H3N2) OF INFLUEZA VIRUS FOR PRODUCING INTRANASAL LIVE INFLUENZA VACCINE FOR ADULTS AND CHILDREN

enthalten in: Europäisches Patentamt | 2015

von DUBROVINA IRINA ANATOL EVNA | LARIONOVA NATAL JA VALENTINOVNA | KISELEVA IRINA VASIL EVNA | +3

110

ATTENUATED COLD-ADAPTED INFLUENZA VIRUS STRAIN A/PR/8/59/M2 (H1N1) APPLICABLE FOR VACCINAL INFLUENZA VIRUS STRAINS AS ATTENUATION DONOR, VACCINAL INFLUENZA VIRUS STRAINS A/59/M2/CALIFORNIA/66/2211 (H2N2) AND A/59/M2/TOKYO/67/22111 (H2N2)

enthalten in: Europäisches Patentamt | 2015

von ISAKOVA-SIVAK IRINA NIKOLAEVNA | RUDENKO LARISA GEORGIEVNA